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The present paper provides a review of the literature regarding exercise testing, exercise capacity, and the role of exercise training
in patients with congenital heart disease (CHD). Diﬀerent measures of exercise capacity are discussed, including both simple and
more advanced exercise parameters. Diﬀerent groups of patients, including shunt lesions, pulmonary valvar stenosis, patients after
completion of Fontan circulation, and patients with pulmonary arterial hypertension are discussed separately in more detail. It
has been underscored that an active lifestyle, taking exercise limitations and potential risks of exercise into account is of utmost
importance.Increasedexercisecapacityinthesepatientsisfurthermorecorrelatedwithanimprovementofobjectiveandsubjective
quality of life.
1.Introduction
In the present era most patients (85%) with congenital heart
disease (CHD) reach adulthood [1]. It has therefore become
of utmost importance to maintain a good quality of life
and physical ﬁtness for these patients. Many studies have
established a moderate to good correlation between quality
of life and exercise capacity [2, 3]. There are, however, many
factors that impede exercise capacity in patients with CHD.
They usually perform less physical activities as compared to
normal controls [4], know little about their own possibilities
[5], and largely overestimate their exercise capacity [6]. In
addition, overprotection from the environment results in
further reductions in physical activity [7].
We therefore reviewed the literature regarding the assess-
ment of exercise capacity, using both simple and more
advanced methods in patients with CHD, the exercise
capacity of patients with CHD, and possibilities of exercising
without considerable risks.
2. ExerciseTesting
Exercise testing is a valuable tool in the management of
pediatric patients with heart disease. It can be used to help
determine the need for medical or surgical interventions and
can be used to determine the eﬃcacy of these interventions
[8–10]. Measurement of exercise capacity and other physio-
logical responses provides objective information about the
functional status of heart, lungs, and peripheral muscles.
This information can be of value in making clinical decisions
resulting in a reduced use of hospital facilities, and improved
functionalcapacityandqualityoflife.Alistofindicationsfor
exercise testing is provided in Table 1.
Although emergencies are rare in pediatric exercise test-
ing [9], staﬀ should be familiar with emergency maneuvers
and the criteria when an exercise test should be terminated
(Table 2). Technical aspects of exercise testing are beyond the
scope of this paper and can be found in the comprehensive
article by Paridon et al. [12].
3. Cardiopulmonary Responses to Exercise
During graded exercise testing, many variables can be mea-
sured. The simplest measures are the assessment of heart rate
(HR) and work rate or endurance time. The measurement of
HR during exercise is simple and inexpensive and provides
important information about the cardiovascular system.2 International Journal of Pediatrics
Table 1: Indications for exercise testing in children.
(1) Assesses physical capacity for recreational, athletic
and occupational recommendations
(2) Evaluates speciﬁc pathophysiologic characteristics
(a) provides indications for surgery, therapy, or
additional tests
(b) evaluates functional postoperative success
(c) diagnoses disease
(3) Assesses adequacy of therapy
(4) Assesses risk for future complications in existing
disease
(5) Instills conﬁdence in child and parents
(6) Motivates child for further exercise or weight loss
Modiﬁed after Bar-Or [11].
Duringexercise,HRincreasesandthehighestobtainedHRis
deﬁned as the HRpeak. In healthy children HRpeak is typically
about 200 ± 10 for treadmill testing and 195 ± 10 for cycle
ergometer testing [9]. After cessation of exercise HR returns
to the baseline. This HR recovery is believed to be mainly
inﬂuenced by vagal autonomic activity, Body Mass Index,
and aerobic capacity [14]. Most studies demonstrate a more
rapid decline in HR after cessation of exercise in younger
children [14, 15]. Studies that determined stroke volume
(SV) show that children have a smaller SV during maximal
exercise compared to adults. Up to moderate submaximal
exercise SV increases, but further increase in cardiac output
(CO) during increasing exercise intensity is in children
regulated by an increase in HR [9]. This means that beyond
moderate intensity exercise (approximately 40% of VO2peak)
a reduced increase in HR will result in reduced CO and,
although partially compensated by a larger arteriovenous
oxygen diﬀerence, a reduction in peak oxygen uptake [16].
When a respiratory gas analysis system is available,
ventilation (VE), oxygen uptake (VO2), and carbon dioxide
production (VCO2) can be measured continuously. Peak
oxygen uptake (VO2peak) is the traditional gold-standard of
aerobiccapacityand isawidely usedparameter. ThisVO2peak
is determined by the maximal rate of the oxygen transport
f r o ml u n g st om u s c l e[ 16], and may be limited by SV, HR, or
tissue extraction. Normal values for VO2peak for children and
adolescents are recently published by ten Harkel et al. [17].
Ventilatory anaerobic threshold (VAT) is another impor-
tant parameter of exercise capacity. It is deﬁned as the point
at which minute ventilation increases disproportionally
relative to VO2, usually occurring at 50–70% of VO2peak
[17]. VAT reﬂects the point at which anaerobic metabolism
starts to increase since oxygen supply cannot keep up
with the increasing metabolic requirements of exercising
muscles [16].
There are several exercise physiological diﬀerences
between children and adults which will not be reviewed
here in detail. In short, during growth, children show a
more marked increase in anaerobic metabolism than aerobic
metabolism as they move through adolescence [18]. When
children perform an increase in exercise work rate, the
increaseinVO2 toanewsteadystate(oxygenuptakekinetics)
ismuchfasterasinadults,andmaybeduetoamoreeﬃcient
oxygen delivery system, a greater relative capacity for oxygen
utilization at the muscle, or both [18].
One of the more recently proposed parameters that can
be obtained during exercise testing is the VE/VCO2 slope.
The VE/VCO2 slope is obtained by linear regression analysis
of ventilation (VE) to carbon dioxide exhalation (VCO2)
as can be continuously measured during exercise during
the complete exercise period. This value reﬂects ventilatory
drive.
Another contemporary parameter that can be obtained
during exercise testing is the Oxygen Uptake Eﬃciency Slope
(OUES). In an attempt to develop an objective and eﬀort-
independent measure of cardiorespiratory ﬁtness in children
with CHD, the OUES was introduced [19]. The OUES
represents the rate of increase of VO2 in response to a given
VE during incremental exercise, indicating how eﬀectively
oxygen is extracted and taken into the body [20]. OUES is
determined from the linear relation of VO2 (y-axis) versus
the logarithm of VE (x-axis) during exercise, that is, VO2 = a
log10 VE + b, where a is the OUES and b is the intercept [20].
The logarithmic transformation of VE is aimed at linearizing
the otherwise curvilinear relation of VO2 versus VE, so
making the OUES theoretically independent of the patient-
achieved eﬀort level. The OUES is a parameter that indicates
the status of both systemic and pulmonary perfusion, and
whichexplainsthehighcorrelationwithVO2peak [19,21,22].
4. ExerciseCapacityinPatients withCHD
Currently, most patients with CHD will survive into adult-
hood. However, residual defects or problems occur relatively
often. Although most patients will report normal exercise
capacity, a reduction in exercise capacity may be the ﬁrst
sign of changes in cardiac function. Many cardiopulmonary
variables may contribute to a reduced exercise capacity,
including systolic and diastolic ventricular dysfunction,
sinus node dysfunction, and changes in cardiac autonomic
nervous activity. Many studies have investigated the exercise
capacity by means of formal exercise testing in these patients
[2, 23–31]. This is important, since many patients grossly
overestimate their physical capabilities. There is only a
poor association between the measured exercise capacity
(e.g., peak oxygen uptake) and the self-reported physical
functioning [6].
Many studies investigating both children and adult
patientswithCHDfoundalowerthannormalHRpeak [2,23–
31]. This lower HRpeak is usually deﬁned as chronotropic
incompetence when less than 80% of the predicted HRpeak
is reached during graded exercise testing, although giv-
ing suﬃcient eﬀort [23]. Factors inﬂuencing HRpeak in
children are intrinsic sinus node dysfunction, and impaired
sympathetic cardiac autonomic nervous activity [32]a s
well as the mode of exercise (e.g., running provides a
somewhathigherHRpeak comparedtocycling).HRdynamics
seem to be more inﬂuenced by the surgeries itself than
by the resultant hemodynamic abnormalities [33]. CardiacInternational Journal of Pediatrics 3
Table 2: Criteria for terminating exercise testing in children with CHD.
(1) Clinical
Symptoms as chest pain, severe headache, dizziness, chills, sustained nausea, inappropriate
dyspnoea
Signs as sustained pallor, clammy skin, disorientation, inappropriate aﬀect
Patient requests termination of the test
(2) Electrocardiography
Failure of heart rate to increase with exercise, and extreme fatigue, dizziness, or other symptoms
suggestive of insuﬃcient cardiac output
Premature ventricular contractions (PVC) with increasing frequency
Ventricular tachycardia (run of >3P V C s )
Supraventricular tachycardia
ST segmental depression, or elevation, of more than 3mm
Triggering of atrioventricular (AV) block (2nd degree AV-block type Mobitz or 3rd degree AV
block) by exercise
Triggering of QTc lengthening >500ms
(3) Blood pressure
Excessive levels (age dependent)—systolic blood pressure >250mmHg, diastolic blood pressure
>125mmHg
Progressive fall in systolic blood pressure with increasing work rate
(4) Progressive fall in oxygen
saturation to <90% or a
10-point drop from resting
saturation in a symptomatic
patient
Modiﬁed from Connuck [8]a n dP a r i d o ne ta l .[ 12].
Table 3: Recommendations for competitive sport participation.
The following congenital heart defects can participate in all sports without restrictions
ASD (closed or small unoperated) and patent foramen ovale (Except Scuba diving in PFO)
VSD (closed or small unoperated)
AVSD (Only mild AV insuﬃciency; no signiﬁcant subaortic stenosis or arrhythmia)
Partial or complete anomalous pulmonary venous connection (No signiﬁcant pulmonary or systemic venous obstruction, no pulmonary
hypertension or exercise-induced arrhythmia)
Persistent ductus arteriosus (operated) (6 months post closure and no residual pulmonary hypertension)
Mild pulmonary stenosis (normal RV, normal ECG)
Mild aortic stenosis (With the exception of high static, high dynamic) (Mean gradient <21 mmHg; no history of arrhythmias, no dizziness,
syncope, or angina pectoris)
Transposition of the great arteries after arterial switch (With the exception of high static, high dynamic) (No or only mild neo-aortic
insuﬃciency; no signiﬁcant pulmonary stenosis; no signs of ischemia or arrhythmia on exercise ECG)
Modiﬁed from Pelliccia et al. [13].
denervation and damage to the sinus node or its blood
supply, leading to sinus node dysfunction may play a role
[33, 34]. Although parasympathetic nervous activity may
improve after surgery, sympathetic reinnervation remains
uncertain [35]. Chronotropic incompetence is also related
to lower exercise capacity and increased levels of NT-pro-
BNP in adults [36]. Disorders mostly related to chronotropic
incompetence were single ventricle physiology (52%), Mus-
tard operation for transposition of the great arteries (46%),
and aortic coarctation (38%) [31], and Eisenmenger patients
(90%) [23]. HR reserve is deﬁned as the diﬀerence between
resting HR and HRpeak, and is physiologically important
since,asdescribedabove,beyondmoderateintensityexercise
a further increase in CO can only be established by a further
increase in HR. A decrease in HR reserve has been related
to a higher mortality risk in adult CHD patients [23].
A slower HR recovery after cessation of exercise indicates
impaired vagal autonomic activity and is usually related
to a lower exercise capacity. This makes the HR recovery
a good indication of vagal tone, and it has been shown
to be a useful marker for evaluating patient outcomes in
cardiac rehabilitation in children with CHD [2]. Cardiac
autonomic nervous activity has also been shown to be useful
in stratifying mild and severe heart failure in pediatric heart
failure patients, due to dilated cardiomyopathy or as a result
of CHD [33]. In some patients, for example, patients after
Fontan operation, cardiac autonomic nervous activity has
been found to be reduced even without signs of heart failure
[37]. The role of the autonomic nervous system has been
studied extensively by Ohuchi et al. [32, 38]. They found in4 International Journal of Pediatrics
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Figure 1: The VE/VCO2 slope in a 13 year old boy with a Fontan
circulation and in a 13-year old healthy boy.
patients with CHD a blunted HR increase during exercise,
and delayed early HR recovery. These were independently
associated with impaired sympathetic and parasympathetic
cardiac autonomic nervous activity [38].
When blood pressure is taken into account, maximal
circulatorypowercanbedeﬁnedasthepeakworkrate(Watt)
× highest mean blood pressure that is reached during peak
exercise. The use of circulatory power as a prognostic marker
is independent from VO2peak and chronotropic incompe-
tence [24]. Peak circulatory power incorporates the blood
pressure response to exercise, and it has been shown that
the pressure-generating ability of the heart is a prognostic
marker in heart failure patients [39]. In adult patients with
CHD this circulatory power is reduced as well [24].
The VO2peak is reduced in most adult patients with CHD,
ranging from a minor reduction in coarctation patients,
to severely impaired VO2peak in Eisenmenger patients [40].
The VE/VCO2 is increased in many CHD patient groups,
being the worst in cyanotic patients with or without
pulmonary hypertension [41]. However, some VSD patients
may show normal values of VE/VCO2 [42]. The increase
in VE/VCO2 slope indicates that in patients with CHD the
ventilation is increased to constrain the fall in arterial pH.
In Fontan patients an increased VE/VCO2 may be related
to intracardiac and intrapulmonary shunting, and may be
further impaired by increased pulmonary vascular resistance
and low CO [41]. An example of a young Fontan patient
is shown in Figure 1. In adults with cyanotic heart disease
the VE/VCO2 slope was most closely related to symptoms of
exercise incapacity [43].
Pulmonary function may play an additional role in
exercise limitations in some CHD patients [44]. Reductions
inforcedexpiratoryvolumein1second,forcedvitalcapacity,
and 1-minute ventilatory volume have all been found in
adults with CHD [45]. As lesions associated with increased
pulmonary blood ﬂow may result in pulmonary vascular
obstructive disease, lesions with reduced pulmonary blood
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Figure 2:TheOUESduringanexercisetestinahealthy13-year-old
boy, in a sex- and age-matched patient with tetralogy of Fallot, and
in a sex- and age-matched Fontan patient.
ﬂow may result in hypoplasia of lung arteries and a reduced
number of alveoli [45]. In operated patients thoracotomies
and cardiopulmonary bypass can lead to increased lung stiﬀ-
ness and thereby further decrease pulmonary function [46].
The oxygen uptake eﬃciency slope (OUES) has been
used in adult heart failure patients, and has shown to be a
reliable parameter, that can be obtained during submaximal
exercise with a good correlation to VO2peak [47]. Exercise
training of these patients results in an improved OUES,
also with a good correlation to the changes in VO2peak [48].
However, OUES in adult cyanotic Fontan patients changes
over the entire exercise duration, which makes it unable
to predict maximal exercise capacity in these patients [49].
However, we observed a linear OUES values in pediatric
Fontan patients with or without cyanosis as well as in
pediatrictetralogyofFallotpatients(Bongersetal.submitted
for publication). In addition we found signiﬁcant diﬀerences
between healthy children and children with CHD (with
FontanandtetralogyofFallotrepair).InFigure 2anexample
of the OUES is provided.
5. ExerciseCapacityinSpeciﬁc Lesions
Shunt Lesions. In patients with a left to right shunt pul-
monary blood ﬂow (Qp) is increased in excess of systemic
blood ﬂow (Qs). A signiﬁcant shunt is usually deﬁned
as a Qp/Qs ratio >2. The most common lesion with left
to right shunting is an atrial septal defect (ASD), and
there are signiﬁcant diﬀerences in exercise capacity between
patients before and after ASD closure. This contrasts to the
unchanged exercise performance in VSD patients, although
only small unoperated VSDs are included in the study of
Binkhorst et al. [50]. They studied a small group of childrenInternational Journal of Pediatrics 5
who had undergone surgical closure of their VSD (N = 13)
or had a small unoperated VSD (N = 14). Exercise capacity
was not signiﬁcantly diﬀerent from controls. Although VSD
patients had a lower participation in sports, and HRpeak was
somewhat lower in the operated patients, these diﬀerences
did not result in diﬀerences of peak work rate or VO2peak as
compared to healthy control subjects [50].
In a large group (N = 52) of adults (38.6±15 years)
w i t ha nA S Dw i t haQ p / Q so f2 . 7 ±0.7, exercise capacity,
was severely reduced before surgery [51]. Although surgery
led to a signiﬁcant improvement in exercise capacity as well
as a decrease in VE/VCO2, in patients with preoperative
signs of pulmonary hypertension exercise capacity remained
b e l o wp r e d i c t e dv a l u e s[ 51]. Also percutaneous ASD closure
in adults led to an improvement in exercise capacity [52].
This increase was irrespective of age at ASD closure, but was
absent in patients with a small atrial shunt (Qp/Qs <2). The
improvement in VO2peak, and oxygen pulse (VO2peak/HRpeak)
was correlated with Qp/Qs before closure [53]. It was found
that the improvement in VO2peak and oxygen pulse were
correlated to an increase in left ventricular ejection fraction
and an increase in left ventricular enddiastolic diameter.
It was concluded that an increase in both left ventricular
SV and CO due to a positive ventricular interaction is the
mechanism leading to improvement in VO2peak [53]. In a
studyofGiardinietal.[54]29adultsbefore,6and36months
after transcatheter ASD closure were studied. A signiﬁcant
improvement in exercise capacity beyond 6 months post
procedure was found. This was irrespective of age at inter-
vention. The improvement was correlated to Qp/Qs before
closure.Theimprovementwasassociatedtoanimprovement
in cardiac form and function. Those patients who did not
reach normal values after 36 months (20%) had a severely
reduced (<50% of predicted) VO2peak before closure.
6. PulmonaryValvar Stenosis
Patients who had surgical repair of an isolated pulmonary
valvar stenosis during childhood show excellent long-term
survival. Exercise capacity, however, is slightly decreased
during long-term (22–33 years) followup as well as HRpeak
[55]. This decrease is related to the development of pul-
monary regurgitation [55]. Also long time after percu-
taneous balloon valvuloplasty of pulmonary stenosis the
development of pulmonary regurgitation is associated with
diminished exercise capacity and a lower VO2peak [56]. In a
group of children and adults with a variety of underlying
CHD and pulmonary stenosis/regurgitation percutaneous
pulmonary valve implantation led to an increase in exercise
capacity, which was related to a reduction of pulmonary
regurgitation [57]. From these studies it has become clear
that especially the development of pulmonary regurgitation
informerpulmonarystenosispatientshasadeleteriouseﬀect
on exercise capacity.
7. FontanCirculation
Exercise capacity and cardiorespiratory responses to exercise
are signiﬁcantly reduced in patients who have undergone the
Fontan procedure [58]. This appears to be due to the absence
of a ventricle in the pulmonary circuit, disadvantageous
systemic ventricular power, increased afterload proﬁle, and
a limited ventricular reserve capacity in these patients.
Several studies have emphasized the ongoing risk for late
failure and poor functional outcome. Ventricular ﬁlling,
which is determined by the pulmonary vascular bed, appears
to be a major determinant of the functional result after
Fontan repair [59]. These ﬁndings have been extensively
studied by Robbers-Visser et al. who determined that under
dobutamine stress there was an abnormal decrease in end-
diastolic volume, and no change in SV [60]. These ﬁndings
further underscore the fact that in the Fontan patients
there is an impaired preload during stress; therefore, CO
(= SV × HR) can be increased only by increasing HR [60].
Interestingly, HRpeak during exercise is signiﬁcantly reduced
in Fontan patients. In a meta-analysis of 25 studies a mean
HRpeak of 153±10 beats/min was reported [61]. This low
HRpeak further compromises increases in CO during exercise
in Fontan patients.
Recently, Muller et al. studied 57 patients after Fontan
completion (age 8–52 years). Exercise capacity was severely
reduced after total cavopulmonary connection (TCPC), cor-
responding to 60% of reference values [62]. This compares
well with the results from 411 children with a Fontan
circulation from 7 Pediatric Heart Network centers, who had
aV O 2peak of 65% of predicted age and gender [63]. Fontan
palliation in early childhood results in a higher VO2peak
during long-term followup [62]. Regular surveillance of the
exercise capacity by spiroergometry is indispensable for the
supervision of patients with Fontan haemodynamics [64]. In
thestudyofMulleretal.dailyactivitiesoftheFontanpatients
was within recommended levels in 72% of the patients [62].
Daily activities were especially reduced in older patients and
inpatientswithalowerVO2peak [62].Anotherstudyobserved
that the activity patterns in Fontan patients were markedly
reduced as well. In a study of 147 Fontan patients, 7–18
years old, measured time spent in moderate and vigorous
activity was markedly below normal at all ages, and was not
signiﬁcantly related to self-reported activity levels [4]. Lower
physical activity levels were signiﬁcantly related to lower
perceivedgeneralhealth[4].SincemostpatientswithFontan
physiology have some degree of cyanosis, an increased
hemoglobin concentration is necessary for adequate oxygen
delivery to the tissues. As in other cyanotic lesions it is
thereforeessentialtopreventirondeﬁciencywhichisdirectly
related to exercise capacity [65].
8. Pulmonary Hypertension
CHD associated with large aortopulmonary shunt and high
pulmonary pressure ﬁnally leads to irreversible pulmonary
arterial hypertension. This situation carries a high risk of
morbidity and mortality. Until recently treatment options
were limited to the avoidance and treatment of complica-
tions. Patients with pulmonary arterial hypertension (PAH)
related to CHD have an extremely low exercise capacity
[66–68].6 International Journal of Pediatrics
The only options to improve exercise capacity is by
reducing the pulmonary arterial hypertension. Bosentan
treatment has been proven to induce short- and mid-
term clinical, exercise, and haemodynamic improvements
in patients with PAH related to CHD [66]. A small but
signiﬁcant improvement in VO2peak was shown from 16.8
± 1.4 to 18.3 ± 1.4mL/kg/min [67]. However, objective
exercise values appear to slowly return to baseline during
longer follow-up periods [68]. The improvement in exercise
capacity has been shown to be correlated to an improvement
in quality of life and stabilization of exercise capacity.
9.PrognosisofImpairedExerciseCapacity
Although a mildly impaired exercise capacity may not
interfere with normal daily life, its relation to prognostic
values makes it an important monitoring tool. However,
theseprognosticmarkershaveasyetonlybeenfoundinadult
CHD patients, while its role during childhood remains as yet
speculative. A reduction in peak circulatory power is related
to the presence of heart failure symptoms, and is a strong
predictor of mortality [24]. Chronotropic incompetence is
related to higher NYHA class, and increased NT-Pro-BNP
[36], and predicts mortality independently of functional
class and VO2peak [23]. A reduction in VO2peak predicts
hospitalization and death [40]. Moreover, an abnormal
VE/VCO2 slope is a strong predictor of death in adult
patients with CHD [41].
10. ExerciseTraininginCongenitalHeart
DiseasePatients
Basic Exercise and Guidelines. Children with CHD run
the risk of becoming overweight and have low levels of
physical activity [69]. A healthy and active lifestyle is as
important in these patients as in the general population
[70]. Regular physical activity is associated with many health
beneﬁts in patients with cardiac disease. Physical exercise
and sports activities have an important beneﬁcial eﬀect on
cardiorespiratory function. The intensity of exercise training
should be adapted to the speciﬁc lesion and to the functional
result obtained [71]. Advances in treatment have resulted
in an increasing population of adults with CHD. Physical
activity in these patients appears to convey beneﬁcial eﬀects,
especially on health-related quality of life [3].
Many prepubertal children with CHD need no restric-
tions in their physical activity. Regular exercise at a recom-
mended level can be performed and should be encouraged
at all ages in all patients with CHD. Many children as well
as adults can attend sports without any restriction [13, 72].
Special concern should be given to those patients with a
signiﬁcantventriculardysfunctionorrecenthistoryorriskof
arrhythmia [72]. Although most patients show a willingness
to participate in exercise, they frequently are uncertain about
safety or beneﬁt [73]. More than 50% of the patients show
a signiﬁcant lack of knowledge about appropriate levels of
physical activity for their cardiac condition [74]. This may
result in the fact that most adult patients fail to achieve
nationalguidelinesforphysicalactivity,rangingfrom77%in
NYHA class I patients to 100% for those who are in NYHA
class III and IV [73]. An important contributing factor to the
impaired exercise capacity is the hypoactive lifestyle, as often
observed in patients with CHD [75]. This frequently results
fromparentalorenvironmentaloverprotection[76].Patients
with CHD should be actively encouraged and stimulated
to adopt an active lifestyle including appropriate exercise
training and sports [70]. General guidelines are provided in
Table 3.
Ingeneral,childrenwithCHDshouldbeadvisedtocom-
ply with public health recommendations of daily participa-
tion in 60 minutes or more of moderate to vigorous physical
activity that is developmentally appropriate, enjoyable, and
involves a variety of activities. Adults with CHD are advised
to perform 30 minutes or more of moderate to vigorous
activities on most days of the week.
11. How EffectiveIs ExerciseTraining?
Most studies in patients with CHD use an adult-type
endurance exercise rehabilitation programme lasting ∼3
months. Usually the training is performed 2-3 times per
week, with an intensity between 60–80% of HRpeak [77].
After these training interventions an improvement in peak
work rate [26, 27]a n dV O 2peak has been found [2, 26, 27].
Thisimprovementpersistedduringa6–12monthsfollow-up
period [2, 27]. Also HR recovery during exercise improved
[2]. The improvement in exercise capacity appeared to be a
result of an increase in the oxygen pulse (=VO2peak/HRpeak)
at peak exercise, while signiﬁcant changes in HRpeak were
not observed [26, 27]. Exercise training may also improve
respiratory muscle oxygenation in children with CHD [78].
These changes were associated with improvements in self-
esteem, behavior, and emotional state [2]. Even a simple
physical activity intervention like regular walking is feasible,
safe, and signiﬁcantly increases the exercise capacity of adult
patients at all stages of CHD [5]. Also for Fontan patients
it is possible to increase exercise capacity by a formal exercise
training program [79].Inseveralstudies withrelativelysmall
numbers of patients, VO2peak and endurance time duration
during exercise testing increased by 10–15%, while HRpeak
remained unchanged [28, 79]. Even patients with severe
chronic PAH can improve signiﬁcantly in exercise capacity
(6-minute walking distance, VAT and VO2peak)a f t e ra1 5
week training program. In this program both moderate
intensity (60–80% of HRpeak) endurance exercise as well as
low intensity resistance training and respiratory exercises as
well were performed [80]. The results from this study show
that formal exercise training is beneﬁcial for patients with
PAH. However, to our knowledge, no studies are available in
pediatric patients with PAH related to CHD.
However, some words of caution are necessary, because
there are many limitations in the designs of these studies. In
manystudies,therewasnocontrolgroup,alargedrop-outof
subjects and no long-term followup of the program. Future
studies should overcome these methodologic shortcomings
as well as design a more child-friendly exercise trainingInternational Journal of Pediatrics 7
program to enhance acceptability and enjoyment which will
result in an improved adherence to the program and long-
term exercise adherence.
12. Conclusion
In this paper, we discussed how exercise capacity can be
measured by using only HR and work rate, or with the use
of respiratory gas analysis in patients with CHD. In addition,
we discussed the exercise capacity of patients with CHD,
and possibilities of physical activity and exercise without
considerable risks as well as exercise rehabilitation. Speciﬁc
attention has been paid to a variety of CHD subgroups.
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